WHO khuyến cáo tránh dùng thuốc ibuprofen trong điều trị COVID-19

Tổ chức Y tế Thế giới (WHO) ngày 17/3 đã khuyến cáo những người đang có các triệu chứng mắc bệnh viêm đường hô hấp cấp COVID-19 tránh sử dụng thuốc chống viêm ibuprofen sau khi Bộ trưởng Y tế Pháp Olivier Veran cảnh báo thuốc chống viêm này có thể làm bệnh tình trầm trọng thêm.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh